These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 1965782)
1. Conjugates of oligonucleotides and modified oligonucleotides: a review of their synthesis and properties. Goodchild J Bioconjug Chem; 1990; 1(3):165-87. PubMed ID: 1965782 [No Abstract] [Full Text] [Related]
2. Alpha-hydroxybenzylphosphonate modified oligonucleotides: synthesis, properties, and a novel route via monomer building blocks. Hohlfeld A; Meier C Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1123-5. PubMed ID: 14565360 [TBL] [Abstract][Full Text] [Related]
3. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development. Orum H; Wengel J Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347 [TBL] [Abstract][Full Text] [Related]
4. Polyamine-oligonucleotide conjugates: a promising direction for nucleic acid tools and therapeutics. Menzi M; Lightfoot HL; Hall J Future Med Chem; 2015; 7(13):1733-49. PubMed ID: 26424049 [TBL] [Abstract][Full Text] [Related]
5. Incorporation of hexose nucleoside analogues into oligonucleotides: synthesis, base-pairing properties and enzymatic stability. Augustyns K; Vandendriessche F; Van Aerschot A; Busson R; Urbanke C; Herdewijn P Nucleic Acids Res; 1992 Sep; 20(18):4711-6. PubMed ID: 1329028 [TBL] [Abstract][Full Text] [Related]
6. 2'-O-Lysylaminohexyl oligonucleotides: modifications for antisense and siRNA. Winkler J; Gilbert M; Kocourková A; Stessl M; Noe CR ChemMedChem; 2008 Jan; 3(1):102-10. PubMed ID: 17979170 [TBL] [Abstract][Full Text] [Related]
7. Backbone modifications in oligonucleotides and peptide nucleic acid systems. De Mesmaeker A; Altmann KH; Waldner A; Wendeborn S Curr Opin Struct Biol; 1995 Jun; 5(3):343-55. PubMed ID: 7583633 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of high quality phosphorothioate oligonucleotides as antisense drugs. Use of I-linker in the elimination of 3'-terminal phosphorothioate monoesters. Ravikumar VT; Kumar RK; Capaldi DC; Cole DL Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):1421-5. PubMed ID: 14565433 [TBL] [Abstract][Full Text] [Related]
9. Comparative inhibition of ras p21 protein synthesis with phosphorus-modified antisense oligonucleotides. Chang EH; Yu Z; Shinozuka K; Zon G; Wilson WD; Strekowska A Anticancer Drug Des; 1989 Oct; 4(3):221-32. PubMed ID: 2679622 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and properties of modified oligonucleotides. Letsinger RL; Alul RA; Farooqui F; Gryaznov SM; Kinstler O Nucleic Acids Symp Ser; 1991; (24):75-8. PubMed ID: 1841386 [TBL] [Abstract][Full Text] [Related]
20. The reactions of H-phosphonates with bifunctional reagents. Part V. Functionalization of support-bound oligonucleotides and synthesis of non-radioactive hybridization probes. Sobkowski M; Kraszewski A; Stawiński J Nucleosides Nucleotides; 1998; 17(1-3):253-67. PubMed ID: 9708350 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]